Dahap, Gwyneth .
HRN: 18-40-60 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2022
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
06/06/2022
06/12/2022
PO
3.5 Ml
Q12
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes